Financhill
Back

First Trust NASDAQ Technology Dividend Index Fund Vs. Akero Therapeutics Industry Stock Comparison

Buy
53

TDIV
First Trust NASDAQ Technology Dividend Index Fund

Last Price:
$92.50
Seasonality Move:
1.23%
Buy
53

AKRO
Akero Therapeutics

Last Price:
$50.14
Seasonality Move:
26.87%
Buy
53
First Trust NASDAQ Technology Dividend Index Fund (TDIV) is a Buy

Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?

  • The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $92.70. The Score for TDIV is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • TDIV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $48.31. The Score for AKRO is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TDIV Stock Price Chart

What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?

  • The First Trust NASDAQ Technology Dividend Index Fund share price today is $92.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TDIV is experiencing slight selling pressure.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $48.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.

TDIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 24.06 Buy
Relative Strength Index (14 RSI): 62.59 Buy
Chaikin Money Flow: -22859 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.56 - 92.22) Buy
Bollinger Bands (100): (73.9 - 90.62) Buy

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.72 Sell
Relative Strength Index (14 RSI): 42.94 Sell
Chaikin Money Flow: 176266 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.58 - 52.42) Sell
Bollinger Bands (100): (40.79 - 53.07) Buy

TDIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.11 Buy
20-day SMA: 91.33 Buy
50-day SMA: 89.56 Buy
200-day SMA: 81.07 Buy
8-day EMA: 86.99 Buy
20-day EMA: 63.74 Buy
50-day EMA: 34.72 Buy
200-day EMA: 10.29 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.56 Sell
20-day SMA: 50.04 Sell
50-day SMA: 52.07 Sell
200-day SMA: 41.69 Buy
8-day EMA: 49.14 Sell
20-day EMA: 49.91 Sell
50-day EMA: 49.95 Sell
200-day EMA: 42.9 Buy

First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.23 per share, and a decrease next year of $0.61 per share.

First Trust NASDAQ Technology Dividend Index Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):